biperiden has been researched along with Cognition Disorders in 6 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Discontinuation of long-term biperiden use may be warranted in patients with schizophrenia treated with SGAs, as it may improve cognitive function, subjective QOL, and psychiatric symptoms with no significant adverse effects." | 7.77 | Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia. ( Anai, K; Arai, J; Funamoto, Y; Ito, Y; Kaneda, Y; Kitajima, R; Kubota, H; Miyake, N; Miyamoto, S; Ogino, S; Ojima, K; Tadokoro, M; Tatsunami, S; Tenjin, T; Tsukahara, S; Yamaguchi, N, 2011) |
| "Discontinuation of long-term biperiden use may be warranted in patients with schizophrenia treated with SGAs, as it may improve cognitive function, subjective QOL, and psychiatric symptoms with no significant adverse effects." | 3.77 | Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia. ( Anai, K; Arai, J; Funamoto, Y; Ito, Y; Kaneda, Y; Kitajima, R; Kubota, H; Miyake, N; Miyamoto, S; Ogino, S; Ojima, K; Tadokoro, M; Tatsunami, S; Tenjin, T; Tsukahara, S; Yamaguchi, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szczodry, O | 1 |
| van der Staay, FJ | 1 |
| Arndt, SS | 1 |
| Veselinović, T | 1 |
| Vernaleken, I | 1 |
| Janouschek, H | 1 |
| Kellermann, T | 1 |
| Paulzen, M | 1 |
| Cumming, P | 1 |
| Gründer, G | 1 |
| Ogino, S | 1 |
| Miyamoto, S | 1 |
| Tenjin, T | 1 |
| Kitajima, R | 1 |
| Ojima, K | 1 |
| Miyake, N | 1 |
| Funamoto, Y | 1 |
| Arai, J | 1 |
| Tsukahara, S | 1 |
| Ito, Y | 1 |
| Tadokoro, M | 1 |
| Anai, K | 1 |
| Tatsunami, S | 1 |
| Kubota, H | 1 |
| Kaneda, Y | 1 |
| Yamaguchi, N | 1 |
| Klinkenberg, I | 1 |
| Blokland, A | 1 |
| Drimer, T | 1 |
| Shahal, B | 1 |
| Barak, Y | 1 |
| Cuesta, MJ | 1 |
| Peralta, V | 1 |
| Zarzuela, A | 1 |
1 trial available for biperiden and Cognition Disorders
| Article | Year |
|---|---|
Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients.
Topics: Aged; Antipsychotic Agents; Biperiden; Cognition Disorders; Dose-Response Relationship, Drug; Drug A | 2004 |
5 other studies available for biperiden and Cognition Disorders
| Article | Year |
|---|---|
Modelling Alzheimer-like cognitive deficits in rats using biperiden as putative cognition impairer.
Topics: Animals; Biperiden; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; M | 2014 |
Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers.
Topics: Adolescent; Adult; Attention; Biperiden; Cognition; Cognition Disorders; Female; Healthy Volunteers; | 2015 |
Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Biperiden; Cognition Disorders; Drug Administration Schedul | 2011 |
A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.
Topics: Animals; Behavior, Animal; Biperiden; Cognition Disorders; Disease Models, Animal; Dose-Response Rel | 2011 |
Empirical validation of competing definitions of schizophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Biperiden; Cognition Disorders; Diagnosis, Differ | 2007 |